Get Your Sales in Shape With the Power of the MET-Rx(R) Brand Name
February 24 2004 - 3:35PM
PR Newswire (US)
Get Your Sales in Shape With the Power of the MET-Rx(R) Brand Name
BOHEMIA, N.Y., Feb. 24 /PRNewswire-FirstCall/ -- NBTY, Inc.
(http://www.nbty.com/). MET-Rx, the premier brand name in sports
nutrition, and the one that fitness-minded consumers look to for
cutting-edge protein & low-carb bars, sports supplements &
drinks, announces its new strategic licensing division -- MET-Rx
Branding. As the leader in the sports nutrition industry -- MET-Rx
is now leveraging its brand strength into new product and service
categories. A MET-Rx license offers great sales potential for you,
as more and more consumers rely on our trusted name for their
fitness and nutritional needs. What's more, the MET-Rx brand is
supported by a multi-million dollar marketing effort ranging from
high profile television sponsorships, including the MET-Rx World's
Strongest Man to high impact national advertising across all
mediums. MET-Rx also builds appeal with its contingent of over 50
top athlete endorsers, including Davana Medina -- 2003 IFBB Figure
Olympia Champion, Bill Kazmaier -- 3 time MET-Rx World's Strongest
Man champion, Susie Curry -- 4 time Ms. Fitness Olympia, as well as
fitness expert Frank Sepe, author of the "Truth" and a regular on
the ESPN show Cold Pizza. With licensed products exceeding $75
billion dollars in U.S. retail sales in 2002, including $10 billion
in sports related products, the MET-Rx name, with its built in
audience, is perfect for branding apparel, sporting goods and
almost any type of accessory. Put the power of the MET-Rx brand to
work for you. Contact Darren Schneider at MET-RX Branding,
1-800-645-5412, or at the MAGIC Marketplace, Las Vegas NV, February
23-26, 2004, MET-RX Branding Booth # AL 14004. MET-Rx Branding.
Where your profits will be Bigger. Better. Stronger. ABOUT NBTY
NBTY is a leading vertically integrated manufacturer and
distributor of a broad line of high-quality, value-priced
nutritional supplements in the United States and throughout the
world. The Company markets approximately 1,500 products under
several brands, including Nature's Bounty(R), Vitamin World(R),
Puritan's Pride(R), Holland & Barrett(R), Rexall(R),
Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R), American
Health(R), GNC (UK)(R) and DeTuinen(R). This release contains
certain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 with respect to
our financial condition, results of operations and business. All of
these forward-looking statements, which can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy which, although believed to be reasonable,
are inherently uncertain. Factors which may materially affect such
forward-looking statements include: (i) slow or negative growth in
the nutritional supplement industry; (ii) interruption of business
ornegative impact on sales and earnings due to acts of war,
terrorism, bio-terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economicand
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance; (xiv) exposure to and expense of defending and
resolving, product liability claims and other litigation; (xv) the
ability of NBTY to successfully implement its business strategy;
(xvi) the inability of NBTY to manage its retail, wholesale,
manufacturing and other operations efficiently; (xvii) consumer
acceptance of NBTY's products; (xviii) the inability of NBTY to
renew leases on its retail locations; (xix) inability of NBTY's
retail stores to attain or maintain profitability; (xx) the absence
of clinical trials for many of NBTY's products; (xxi) sales and
earnings volatility and/or trends; (xxii) the efficacy of NBTY's
Internet and on-line sales and marketing; (xxiii) fluctuations in
foreign currencies, including the British Pound; (xxiv)
import-export controls on sales to foreign countries; (xxv) the
inability of NBTY to secure favorable new sites for, and delays in
opening, new retail locations; (xxvi) introduction of new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the
banning of products) and more particularly the Food Supplements
Directive and the Traditional Herbal Medicinal Products Directive
in Europe; (xxvii) the mix of NBTY's products and the profit
margins thereon; (xxviii) the availability and pricing of raw
materials; (xxix) risk factors discussed in NBTY's filings with the
U.S. Securities and Exchange Commission; and (xxx) other factors
beyond NBTY's control. Readers are cautioned not to place undue
reliance on forward-looking statements. NBTY cannot guarantee
future results, trends, events, levels of activity, performance or
achievements. NBTY does not undertake and specifically declines any
obligation to update, republish or revise forward- looking
statements to reflect events or circumstances after the date hereof
or to reflect the occurrences of unanticipated events. DATASOURCE:
NBTY, Inc. CONTACT: Harvey Kamil, President and CFO of NBTY, Inc.,
+1-631-244-2020; or Carl Hymans of G.S. Schwartz & Co.,
+1-212-725-4500, , for NBTY, Inc. Web site: http://www.nbty.com/
Copyright
N B T Y (NYSE:NTY)
Historical Stock Chart
From Sep 2024 to Oct 2024
N B T Y (NYSE:NTY)
Historical Stock Chart
From Oct 2023 to Oct 2024